a week ago NVAX received 388M in funding pushing the stock up to ath of $61.50. I would say profit taking pushed the stock down to its current level @ $46-ish. Recent news on new human trials to begin in July enough to Push stock back up ATH? Any feedback would be awesome.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.